The mechanism by which GLP-1 RAs potentially increase suicide or suicide attempts is unclear but may involve an overactivation of the hypothalamic-pituitary-adrenal (HPA) axis [7], rapid weight loss [8], and reduced expression of brain-derived neurotrophic factor which may link weight changes to heightened anxiety and suicidal risk [9]
The SURMOUNT-1 trial showed an average weight loss of 22.5% at the highest dose over 72 weeks (Jastreboff et al., 2022)
Gala GLP-1 follows this model, with one subscription price covering consultations, medication fulfillment, dosage adjustments, and asynchronous provider messaging
Clinical trial data from the STEP program provides detailed insight into expected results at each stage
Uboveja A, Huang Z, Buj R, Amalric A, Wang H, Tangudu NK et al
Rybelsus is mainly for type 2 diabetes, while the Wegovy pill and Foundayo are for weight loss